337 related articles for article (PubMed ID: 27510172)
1. How FSH and AMH reflect probabilities of oocyte numbers in poor prognosis patients with small oocyte yields.
Gleicher N; Darmon SK; Kushnir VA; Weghofer A; Wang Q; Zhang L; Albertini DF; Barad DH
Endocrine; 2016 Nov; 54(2):476-483. PubMed ID: 27510172
[TBL] [Abstract][Full Text] [Related]
2. Discordances between follicle stimulating hormone (FSH) and anti-Müllerian hormone (AMH) in female infertility.
Gleicher N; Weghofer A; Barad DH
Reprod Biol Endocrinol; 2010 Jun; 8():64. PubMed ID: 20565808
[TBL] [Abstract][Full Text] [Related]
3. [Low circulating anti-Müllerian hormone and normal follicle stimulating hormone levels: which prognosis in an IVF program?].
Grzegorczyk-Martin V; Khrouf M; Bringer-Deutsch S; Mayenga JM; Kulski O; Cohen-Bacrie P; Benaim JL; Belaisch-Allart J
Gynecol Obstet Fertil; 2012; 40(7-8):411-8. PubMed ID: 22521986
[TBL] [Abstract][Full Text] [Related]
4. Discordant anti-müllerian hormone (AMH) and follicle stimulating hormone (FSH) among women undergoing in vitro fertilization (IVF): which one is the better predictor for live birth?
Wang S; Zhang Y; Mensah V; Huber WJ; Huang YT; Alvero R
J Ovarian Res; 2018 Jul; 11(1):60. PubMed ID: 30012195
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of anti-müllerian hormone, follicle-stimulating hormone and antral follicle count on the outcome of ovarian stimulation in women following GnRH-antagonist protocol for IVF/ET.
Tsakos E; Tolikas A; Daniilidis A; Asimakopoulos B
Arch Gynecol Obstet; 2014 Dec; 290(6):1249-53. PubMed ID: 25001569
[TBL] [Abstract][Full Text] [Related]
6. Relationship Between Anti-Müllerian Hormone and
Sun XY; Lan YZ; Liu S; Long XP; Mao XG; Liu L
Front Endocrinol (Lausanne); 2020; 11():595448. PubMed ID: 33343511
[TBL] [Abstract][Full Text] [Related]
7. Anti-Mullerian hormone is a better marker than inhibin B, follicle stimulating hormone, estradiol or antral follicle count in predicting the outcome of in vitro fertilization.
Kunt C; Ozaksit G; Keskin Kurt R; Cakir Gungor AN; Kanat-Pektas M; Kilic S; Dede A
Arch Gynecol Obstet; 2011 Jun; 283(6):1415-21. PubMed ID: 21562964
[TBL] [Abstract][Full Text] [Related]
8. AMH has no role in predicting oocyte quality in women with advanced age undergoing IVF/ICSI cycles.
Dai X; Wang Y; Yang H; Gao T; Yu C; Cao F; Xia X; Wu J; Zhou X; Chen L
Sci Rep; 2020 Nov; 10(1):19750. PubMed ID: 33184364
[TBL] [Abstract][Full Text] [Related]
9. Live-birth rates in very poor prognosis patients, who are defined as poor responders under the Bologna criteria, with nonelective single embryo, two-embryo, and three or more embryos transferred.
Gleicher N; Vega MV; Darmon SK; Weghofer A; Wu YG; Wang Q; Zhang L; Albertini DF; Barad DH; Kushnir VA
Fertil Steril; 2015 Dec; 104(6):1435-41. PubMed ID: 26348275
[TBL] [Abstract][Full Text] [Related]
10. Use of ovarian reserve parameters for predicting live births in women undergoing in vitro fertilization.
Lukaszuk K; Kunicki M; Liss J; Lukaszuk M; Jakiel G
Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):173-7. PubMed ID: 23485092
[TBL] [Abstract][Full Text] [Related]
11. Clinical relevance of combined FSH and AMH observations in infertile women.
Gleicher N; Kim A; Kushnir V; Weghofer A; Shohat-Tal A; Lazzaroni E; Lee HJ; Barad DH
J Clin Endocrinol Metab; 2013 May; 98(5):2136-45. PubMed ID: 23533225
[TBL] [Abstract][Full Text] [Related]
12. Follicle stimulating hormone and anti-Müllerian hormone per oocyte in predicting in vitro fertilization pregnancy in high responders: a cohort study.
Weghofer A; Kim A; Barad DH; Gleicher N
PLoS One; 2012; 7(4):e34290. PubMed ID: 22545082
[TBL] [Abstract][Full Text] [Related]
13. The use of anti-Müllerian hormone and antral follicle count to predict the potential of oocytes and embryos.
Majumder K; Gelbaya TA; Laing I; Nardo LG
Eur J Obstet Gynecol Reprod Biol; 2010 Jun; 150(2):166-70. PubMed ID: 20223579
[TBL] [Abstract][Full Text] [Related]
14. Toward a better understanding of functional ovarian reserve: AMH (AMHo) and FSH (FSHo) hormone ratios per retrieved oocyte.
Gleicher N; Kim A; Weghofer A; Barad DH
J Clin Endocrinol Metab; 2012 Mar; 97(3):995-1004. PubMed ID: 22170712
[TBL] [Abstract][Full Text] [Related]
15. Definition by FSH, AMH and embryo numbers of good-, intermediate- and poor-prognosis patients suggests previously unknown IVF outcome-determining factor associated with AMH.
Gleicher N; Kushnir VA; Sen A; Darmon SK; Weghofer A; Wu YG; Wang Q; Zhang L; Albertini DF; Barad DH
J Transl Med; 2016 Jun; 14(1):172. PubMed ID: 27286817
[TBL] [Abstract][Full Text] [Related]
16. Specific ranges of anti-Mullerian hormone and antral follicle count correlate to provide a prognostic indicator for IVF outcome.
Keane K; Cruzat VF; Wagle S; Chaudhary N; Newsholme P; Yovich J
Reprod Biol; 2017 Mar; 17(1):51-59. PubMed ID: 28132758
[TBL] [Abstract][Full Text] [Related]
17. Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients.
Arce JC; La Marca A; Mirner Klein B; Nyboe Andersen A; Fleming R
Fertil Steril; 2013 May; 99(6):1644-53. PubMed ID: 23394782
[TBL] [Abstract][Full Text] [Related]
18. Utility of age-specific serum anti-Müllerian hormone concentrations.
Barad DH; Weghofer A; Gleicher N
Reprod Biomed Online; 2011 Mar; 22(3):284-91. PubMed ID: 21269880
[TBL] [Abstract][Full Text] [Related]
19. Assessment of ovarian reserve with anti-Müllerian hormone: a comparison of the predictive value of anti-Müllerian hormone, follicle-stimulating hormone, inhibin B, and age.
Riggs RM; Duran EH; Baker MW; Kimble TD; Hobeika E; Yin L; Matos-Bodden L; Leader B; Stadtmauer L
Am J Obstet Gynecol; 2008 Aug; 199(2):202.e1-8. PubMed ID: 18674663
[TBL] [Abstract][Full Text] [Related]
20. What number of oocytes is appropriate for defining poor ovarian response?
Kim SK; Lee JR; Jee BC; Suh CS; Kim SH
Yonsei Med J; 2015 Mar; 56(2):482-9. PubMed ID: 25683999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]